Table of Contents: 1 Executive Summary 1.1 Market Attractiveness Analysis 2 Market Introduction 2.1 Definition 2.2 Scope of the Study 2.3 Assumptions 2.4 Market Structure 3 Research Methodology 3.1 Research Process 3.2 Primary Research 3.3 Secondary Research 3.4 Market Size Estimation 3.5 Forecast Model 4 Market Dynamics 4.1 Introduction 4.2 Drivers 4.2.1 Increasing R&D Activities by Biopharmaceutical and Pharmaceutical Companies 4.2.2 Growing Expenditure in The Development of Clinical Trials 4.2.3 Rising Burden of Chronic Diseases 4.2.4 Increased Use of Smart Devices for Healthcare Management 4.3 Restraints 4.3.1 Shortage of Healthcare Professionals and Patients for Clinical Trials 4.3.2 Security and Confidentiality of Data 4.4 Opportunities 4.4.1 Increasing R&D for Precision Medicine Will Strengthen the Market for eClinical Solutions 4.5 Mega Trends 5 Market Factor Analysis 5.1 Value Chain Analysis 5.1.1 Inputs 5.1.2 Software Development Process 5.1.3 Output 5.1.4 Marketing and Distribution 5.1.5 Post-Selling Services 5.2 Porter’s Five Forces Model 5.2.1 Threat of New Entrants 5.2.2 Bargaining Power of Suppliers 5.2.3 Bargaining Power of Buyers 5.2.4 Threat of Substitutes 5.2.5 Intensity of Rivalry 5.3 Regulatory Framework 6 Global eClinical Solutions Market, by Type 6.1 Introduction 6.2 Clinical Data Management System (CDMS) 6.3 Randomization and Trial Supply Management (RTSM) 6.4 Electronic Clinical Outcome Assessment (eCOA) 6.5 Clinical Trial Management System (CTMS) 6.6 Electronic Trail Master Files (eTMF) 6.7 Trial Safety & Regulatory 7 Global eClinical Solutions Market, by Delivery Mode 7.1 Introduction 7.2 Web Based and Cloud Based 7.3 Enterprise Based 8 Global eClinical Solutions Market, by Clinical Trial Phase 8.1 Introduction 8.2 Phase I 8.3 Phase II 8.4 Phase III 8.5 Phase IV 9 Global eClinical Solutions Market, by End User 9.1 Introduction 9.2 Contract Research Organizations (CROs) 9.3 Pharma/Biotech Companies 10 Global eClinical Solutions Market, by Region 10.1 Introduction 10.2 Americas 10.2.1 North America 10.2.1.1 US 10.2.1.2 Canada 10.2.2 Latin America 10.3 Europe 10.3.1 Western Europe 10.3.1.1 Germany 10.3.1.2 UK 10.3.1.3 France 10.3.1.4 Italy 10.3.1.5 Spain 10.3.1.6 Rest of Western Europe 10.3.2 Eastern Europe 10.4 Asia-Pacific 10.4.1 Japan 10.4.2 China 10.4.3 India 10.4.4 Australia 10.4.5 South Korea 10.4.6 Rest of Asia-Pacific 10.5 Middle East & Africa 10.5.1 Middle East 10.5.2 Africa 11 Competitive Landscape 11.1 Company Market Share Analysis 11.1.1 Introduction 12 Company Profiles 12.1 ERT Clinical 12.1.1 Company Overview 12.1.2 Financial Overview 12.1.3 Products/Services Offered 12.1.4 Key Developments 12.1.5 SWOT Analysis 12.1.6 Key Strategies 12.2 Parexel International Corporation 12.2.1 Company Overview 12.2.2 Financial Overview 12.2.3 Products/Services Offered 12.2.4 Key Developments 12.2.5 SWOT Analysis 12.2.6 Key Strategies 12.3 BioClinica, Inc. 12.3.1 Company Overview 12.3.2 Financial Overview 12.3.3 Products/Services Offered 12.3.4 Key Developments 12.3.5 SWOT Analysis 12.3.6 Key Strategies 12.4 CRF Health 12.4.1 Company Overview 12.4.2 Financial Overview 12.4.3 Products/Services Offered 12.4.4 Key Developments 12.4.5 SWOT Analysis 12.4.6 Key Strategies 12.5 Oracle Corporation 12.5.1 Company Overview 12.5.2 Financial Overview 12.5.3 Products/Services Offered 12.5.4 Key Developments 12.5.5 SWOT Analysis 12.5.6 Key Strategies 12.6 Datatrak Int. 12.6.1 Company Overview 12.6.2 Financial Overview 12.6.3 Products/Services Offered 12.6.4 Key Developments 12.6.5 SWOT Analysis 12.6.6 Key Strategies 12.7 Merge Healthcare Inc. 12.7.1 Company Overview 12.7.2 Financial Overview 12.7.3 Products/Services Offered 12.7.4 Key Developments 12.7.5 SWOT Analysis 12.7.6 Key Strategies 12.8 Medidata Solutions, Inc. 12.8.1 Company Overview 12.8.2 Financial Overview 12.8.3 Products/Services Offered 12.8.4 Key Developments 12.8.5 SWOT Analysis 12.8.6 Key Strategies 12.9 Omnicomm Systems, Inc. 12.9.1 Company Overview 12.9.2 Financial Overview 12.9.3 Products/Services Offered 12.9.4 Key Developments 12.9.5 SWOT Analysis 12.9.6 Key Strategies 12.1 MaxisIT 12.10.1 Company Overview 12.10.2 Financial Overview 12.10.3 Products Offering 12.10.4 Key Developments 12.10.5 SWOT Analysis 12.10.6 Key Strategies 13 Appendix 13.1 References 13.2 Related Reports

List of Tables: TABLE 1 GLOBAL ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 2 GLOBAL ECLINICAL SOLUTIONS MARKET FOR CLINICAL DATA MANAGEMENT SYSTEM (CDMS), BY REGION, 2015–2023 (USD MILLION) TABLE 3 GLOBAL ECLINICAL SOLUTIONS MARKET FOR RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM), BY REGION, 2015–2023 (USD MILLION) TABLE 4 GLOBAL ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA), BY REGION, 2015–2023 (USD MILLION) TABLE 5 GLOBAL ECLINICAL SOLUTIONS MARKET FOR CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS), BY REGION, 2015–2023 (USD MILLION) TABLE 6 GLOBAL ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC TRAIL MASTER FILES (ETMF), BY REGION, 2015–2023 (USD MILLION) TABLE 7 GLOBAL ECLINICAL SOLUTIONS MARKET FOR TRIAL SAFETY & REGULATORY, BY REGION, 2015–2023 (USD MILLION) TABLE 8 GLOBAL ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 9 GLOBAL ECLINICAL SOLUTIONS MARKET FOR WEB BASED AND CLOUD BASED, BY REGION, 2015–2023 (USD MILLION) TABLE 10 GLOBAL ECLINICAL SOLUTIONS MARKET FOR ENTERPRISE BASED, BY REGION, 2015–2023 (USD MILLION) TABLE 11 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 12 GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHASE I, BY REGION, 2015–2023 (USD MILLION) TABLE 13 GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHASE II, BY REGION, 2015–2023 (USD MILLION) TABLE 14 GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHASE III, BY REGION, 2015–2023 (USD MILLION) TABLE 15 GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHASE IV, BY REGION, 2015–2023 (USD MILLION) TABLE 16 GLOBAL ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 17 GLOBAL ECLINICAL SOLUTIONS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2015–2023 (USD MILLION) TABLE 18 GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHARMA/BIOTECH COMPANIES, BY REGION, 2015–2023 (USD MILLION) TABLE 19 GLOBAL ECLINICAL SOLUTIONS MARKET, BY REGION, 2015–2023 (USD MILLION) TABLE 20 AMERICAS: ECLINICAL SOLUTIONS MARKET, BY REGION, 2015–2023 (USD MILLION) TABLE 21 AMERICAS: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 22 AMERICAS: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 23 AMERICAS: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 24 AMERICAS: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 25 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2015–2023 (USD MILLION) TABLE 26 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 27 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 28 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 29 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 30 US: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 31 US: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 32 US: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 33 US: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 34 CANADA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 35 CANADA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 36 CANADA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 37 CANADA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 38 LATIN AMERICA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 39 LATIN AMERICA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 40 LATIN AMERICA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 41 LATIN AMERICA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 42 EUROPE: ECLINICAL SOLUTIONS MARKET, BY REGION, 2015–2023 (USD MILLION) TABLE 43 EUROPE: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION) TABLE 44 EUROPE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 45 EUROPE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 46 EUROPE: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION) TABLE 47 WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2015–2023 (USD MILLION) TABLE 48 WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION) TABLE 49 WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 50 WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 51 WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION) TABLE 52 GERMANY: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION) TABLE 53 GERMANY: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 54 GERMANY: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 55 GERMANY: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION) TABLE 56 UK: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION) TABLE 57 UK: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 58 UK: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 59 UK: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION) TABLE 60 FRANCE: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION) TABLE 61 FRANCE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 62 FRANCE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 63 FRANCE: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION) TABLE 64 ITALY: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION) TABLE 65 ITALY: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 66 ITALY: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 67 ITALY: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION) TABLE 68 SPAIN: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION) TABLE 69 SPAIN: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 70 SPAIN: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 71 SPAIN: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION) TABLE 72 REST OF WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION) TABLE 73 REST OF WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 74 REST OF WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 75 REST OF WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION) TABLE 76 EASTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION) TABLE 77 EASTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 78 EASTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 79 EASTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION) TABLE 80 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2015–2023 (USD MILLION) TABLE 81 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 82 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 83 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 84 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 85 JAPAN: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 86 JAPAN: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 87 JAPAN: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 88 JAPAN: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 89 CHINA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 90 CHINA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 91 CHINA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 92 CHINA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 93 INDIA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 94 INDIA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 95 INDIA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 96 INDIA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 97 AUSTRALIA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 98 AUSTRALIA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 99 AUSTRALIA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 100 AUSTRALIA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 101 SOUTH KOREA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 102 SOUTH KOREA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 103 SOUTH KOREA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 104 SOUTH KOREA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 105 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION) TABLE 106 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 107 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 108 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION) TABLE 109 MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET, BY REGION, 2015–2023 (USD MILLION) TABLE 110 MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION) TABLE 111 MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 112 MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 113 MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION) TABLE 114 MIDDLE EAST: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION) TABLE 115 MIDDLE EAST: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 116 MIDDLE EAST: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 117 MIDDLE EAST: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION) TABLE 118 AFRICA: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION) TABLE 119 AFRICA: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION) TABLE 120 AFRICA: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION) TABLE 121 AFRICA: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION)List of Figures: FIGURE 1 MARKET SYNOPSIS FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL ECLINICAL SOLUTIONS MARKET FIGURE 3 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY TYPE, 2017 (%) FIGURE 4 GLOBAL ECLINICAL SOLUTIONS MARKET, BY TYPE, 2016–2023 (USD MILLION) FIGURE 5 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY DELIVERY MODE, 2017 (%) FIGURE 6 GLOBAL ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2016–2023 (USD MILLION) FIGURE 7 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY CLINICAL TRIAL PHASE, 2017 (%) FIGURE 8 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2016–2023 (USD MILLION) FIGURE 9 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY END USER, 2017 (%) FIGURE 10 GLOBAL ECLINICAL SOLUTIONS MARKET, BY END USER, 2016–2023 (USD MILLION) FIGURE 11 GLOBAL ECLINICAL SOLUTIONS MARKET: MARKET STRUCTURE FIGURE 12 RESEARCH PROCESS OF MRFR FIGURE 13 TOP-DOWN & BOTTOM-UP APPROACH FIGURE 14 MARKET DYNAMICS: ANALYSIS OF GLOBAL ECLINICAL SOLUTIONS MARKET FIGURE 15 VALUE CHAIN: GLOBAL ECLINICAL SOLUTIONS MARKET FIGURE 16 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL ECLINICAL SOLUTIONS MARKET FIGURE 17 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY TYPE, 2017(%) FIGURE 18 GLOBAL ECLINICAL SOLUTIONS MARKET, BY TYPE, 2017 & 2023 (USD MILLION) FIGURE 19 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY DELIVERY MODE, 2017 (%) FIGURE 20 GLOBAL ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2017 & 2023 (USD MILLION) FIGURE 21 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY CLINICAL TRIAL PHASE, 2017(%) FIGURE 22 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017 & 2023 (USD MILLION) FIGURE 23 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY END USER, 2017(%) FIGURE 24 GLOBAL ECLINICAL SOLUTIONS MARKET, BY END USER, 2017 & 2023 (USD MILLION) FIGURE 25 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY REGION, 2017(%) FIGURE 26 GLOBAL ECLINICAL SOLUTIONS MARKET, BY REGION, 2017 & 2023 (USD MILLION) FIGURE 27 AMERICAS: ECLINICAL SOLUTIONS MARKET SHARE, BY REGION, 2017 (%) FIGURE 28 EUROPE: ECLINICAL SOLUTIONS MARKET SHARE, BY REGION, 2017 (%) FIGURE 29 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SHARE, BY COUNTRY, 2017 (%) FIGURE 30 MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET SHARE, BY REGION, 2017 (%) FIGURE 31 GLOBAL ECLINICAL SOLUTIONS MARKET, MARKET SHARE ANALYSIS, 2017 (% SHARE)

ERT Clinical, PAREXEL International Corporation, BioClinica, Inc., CRF Health, Oracle Corporation, DATATRAK International, Inc., Merge Healthcare Inc, Medidata Solutions, Inc., Omnicomm Systems, Inc. and MaxisIT